Research study · Journal of Clinical Child & Adolescent Psychology · 2026
Evidence Base on Outpatient Behavioral Treatments for Adolescent Substance Use, Update 2018-2023: Current Status, Best Practices, and Opportunities for Advancing the Science
Verified on PubMed Systematic review or meta-analysis
A 2026 systematic review in Journal of Clinical Child & Adolescent Psychology in substance-related disorders. The overall picture did not change much from earlier reviews, and the results for marijuana and opioids were mixed. This review does not show that any single treatment cures teenage substance use, and it does not compare dosing or medication.
In plain language
Study overview
This review looked at the latest research on counseling-based treatments for teenagers who use alcohol or drugs and are seen as outpatients, meaning they live at home and visit a clinic. It covered studies published from 2018 to 2023 and reviewed what works best, with a focus on marijuana and opioid use. The authors compared the findings against earlier reviews.
Findings
The overall picture did not change much from earlier reviews, and the results for marijuana and opioids were mixed. Treatments that involve the family and certain talk-based therapies remain the best supported, but there was little new research specifically on marijuana or opioid use in teenagers.
The deeper readScientific analysis
Objective: This systematic review (1) updates the evidence base on outpatient behavioral treatments for adolescent substance use (ASU) since publication of the previous review completed for this journal by Hogue, Henderson, Becker, and Knight (2018); and (2) addresses public health concerns related to youth marijuana and opioid use. Method: We first summarize the earlier updates, along with those from recent literature reviews and meta-analytic studies, of ASU treatments. We then present study design and methods criteria used to identify five comparative studies subjected to JCCAP level of support evaluation. We detail these five studies in terms of their sample characteristics, quality of evidence, and substance use outcomes. Cumulative level of support designations are then made for each identified treatment approach. Results: These cumulative designations are identical to those of the previous review: ecological family-based treatment, individual cognitive-behavioral therapy, and group cognitive-behavioral therapy are Well-Established; behavioral family-based treatment and motivational interviewing are Probably Efficacious; drug counseling is Possibly Efficacious; and five multicomponent treatments (three of which include contingency management) are Well-Established or Probably Efficacious. Conclusions: To address pressing issues in ASU treatment, we discuss best practices and promising research on behavioral and medication interventions for marijuana use and opioid use. We conclude with opportunities for advancing ASU treatment science in the areas of technology-based intervention, co-occurring disorders, addiction recovery, and access to and delivery of evidence-based approaches.
The paper
Citation
Hogue A, Porter NP, Henderson CE, Ozechowski TJ, Wenzel K, Fishman M, et al. Evidence Base on Outpatient Behavioral Treatments for Adolescent Substance Use, Update 2018–2023: Current Status, Best Practices, and Opportunities for Advancing the Science. Journal of Clinical Child & Adolescent Psychology (2026). PubMed 40758942 · DOI
Limitations the authors noted
Only five studies met the strict JCCAP methodological criteria, limiting the breadth of the evidence base. Included studies had small or imprecise samples and non-negligible attrition; several rated moderate or low strength of evidence. Search restricted to English-language records in Web of Science from 2017 onward, with search terms and inclusion criteria that may have excluded relevant studies. Opioid use disorder and nicotine studies were excluded by design, so opioid-specific conclusions rely on non-randomized or adult evidence. Heterogeneity in samples (predominantly male or Hispanic/Latinx in several trials), outcome measures, and follow-up windows limits generalizability and moderator conclusions.
In practice
Why this matters
This review does not show that any single treatment cures teenage substance use, and it does not compare dosing or medication options. It suggests that family-involved and talk-based approaches are still the best-supported starting points for teens, while the evidence for marijuana and opioid use specifically is thin. Clinicians should treat these conclusions as a current snapshot of a small body of research, not as settled proof for any individual.
Browse related research
Condition: Substance-related disorders
Related on CED Clinic
Back to Daily Research and Patient Questions
Reviewed by Dr. Caplan on October 13, 2026.
This page is general education about a published study. It is not medical advice and does not create a doctor-patient relationship. For care specific to you, book a consultation.